Leucovorin calcium ANDA suitability petitions
Burroughs-Wellcome asked FDA for permission on file an ANDA for a 100 mg sterile powder version of Lederle's 50 mg injectable. B-W already markets Wellcovorin liquid and tablets. Besides proposing a higher strength, B-W proposed to deviate from Lederle's labeling by borrowing from the Wellcovorin tablet labeling the clinical pharmacology, indications and usage, contraindications, warnings, precautions, overdosage, and dosage and administration sections. Wellcovorin labeling "contains the most up-to-date prescribing information [and] a better presentation of content and format," the firm said. In addition, Quad Pharmaceuticals asked to submit an ANDA for a 10 mg/ml, 5 ml sterile fill solution, and David Bull Labs, Ltd. proposed an ANDA for a 10 mg/ml concentration.
You may also be interested in...
Despite AI and digital analytics playing an increasing role in pharma, the industry lags others globally, a recent event heard. Meanwhile, top Indian players including Sun Pharma, Cipla and others shared what is driving their initiatives, ranging from a 'touchless factory' to virtual training and lessons learned along the way.
Hologic made its third big acquisition of 2021 and Agilent agreed to pay up to $695m for Resolution Bioscience to extend its precision oncology capabilities.
Broader than initially reported, Merck & Co.’s agreement with BARDA extends beyond J&J’s recently authorized vaccine to other COVID-19 vaccines and therapeutics as needed.